お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
981839

病院用注射剤販売の世界市場(2020年)

Global Hospital Injectable Drugs Sales Market Report 2020

出版日: | 発行: QYResearch | ページ情報: 英文 119 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.78円
病院用注射剤販売の世界市場(2020年)
出版日: 2021年01月08日
発行: QYResearch
ページ情報: 英文 119 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の病院用注射剤の市場規模は、2019年に380億米ドルと評価され、2021年から2026年まで4.7%のCAGRで拡大し、2026年には510億米ドルに達すると予測されています。

2019年、世界のジェネリック無菌注射剤の市場規模は288億米ドルで、2026年には364億米ドルに達し、2021年から2026年のCAGRは3.5%となる見込みです。

また、無菌静脈内(IV)溶液の世界の市場規模は2019年に91億米ドルとなり、2026年までに146億米ドルに達し、2021年から2026年のCAGRは8.1%となる見通しです。

ジェネリック無菌注射剤の分野では、Hospira(Pfizer Inc.)が最大の企業であり、Fresenius Kabi が2番手です。 2019年の上位2社のシェアは約27%です。米国市場は、Hospira(Pfizer Inc。)、Fresenius Kabi Sandoz(Novartis)、Hikma Pharmaceuticals PLC、Dr. Reddy's Laboratories Ltd、Grifols、Nichi Iko Group(Sagent)、Teva Pharmaceutical、Auromedics、Sanofi、Gland Pharma、Endo International PLCなどによって支配されています。

無菌静脈内(IV)溶液のセグメントでは、Baxterが最大の企業であり、Fresenius KabiとSichuan Kelun Pharmaceuticalが2番手と3番手です。 2019年の上位3社のシェアは65%を超えています。北米と欧州の市場は、 Baxter、Fresenius Kabi、B. Braunなどの少数の企業によって支配されています。そして日本では、大塚製薬が日本市場のほぼ50%のシェアを占めています。中国市場では、業界の集中度は低く、中国には多くの小規模企業がいます。

当レポートでは、世界の病院用注射剤販売市場について調査分析し、市場規模、市場状況、競合情勢、市場シェア、成長率、将来動向、市場成長要因、機会・課題、販売チャネル・販売代理店などについて、体系的な情報を提供しています。

目次

第1章 病院用注射剤市場の市場概要

  • 病院用注射剤製品の範囲
  • 製品別の病院用注射剤セグメント
    • 製品別の世界の病院注射剤販売(2020年および2026年)
    • ジェネリック無菌注射剤
    • 無菌静脈内(IV)溶液
  • アプリケーション別市場セグメント
    • アプリケーション別売上高の比較(2020年~2026年)
    • 腫瘍学
    • 麻酔
    • 抗感染薬
    • 非経口栄養剤
    • 心血管疾患
  • 世界の病院注射薬市場推計・予測(2015年~2026年)

第2章 地域別市場の推計・予測

  • 地域別市場規模:2015年、2020年、2026年
  • 地域別市場シナリオ(2015年~2020年)
  • 市場推計・予測と地域別予測(2021年~2026年)
  • 地域別市場分析:市場の詳細データ
    • 北米市場の推計・予測(2015年~2026年)
    • 欧州市場の推計・予測(2015年~2026年)
    • 中国市場の推計・予測(2015年~2026年)
    • 日本市場の推定と予測(2015年~2026年)
    • 東南アジア市場の推計・予測(2015年~2026年)
    • インド市場の推計・予測(2015年~2026年)

第3章 競合情勢

  • 売上高別世界のトップ企業(2015年~2020年)
  • 企業別ジェネリック無菌注射剤の売上高
  • 企業別無菌静脈内(IV)溶液販売
  • メーカーの製造拠点、提供地域、製品タイプ
  • メーカーの合併・買収、拡張計画

第4章 製品別市場規模

  • 製品別市場レビュー(2015年~2020年)
  • 市場推計・予測と製品別予測(2021年~2026年)

第5章 アプリケーション別市場規模

  • アプリケーション別市場レビュー(2015年~2020年)
  • 市場推計・予測とアプリケーション別予測(2021年~2026年)

第6章 北米市場の詳細データ

  • 製品別市場シェア(2015年~2020年)
  • アプリケーション別市場シェア(2015年~2020年)

第7章 欧州市場の詳細データ

  • 製品別市場シェア(2015年~2020年)
  • アプリケーション別市場シェア(2015年~2020年)

第8章 中国市場の詳細データ

  • 製品別市場シェア(2015年~2020年)
  • アプリケーション別市場シェア(2015年~2020年)

第9章 日本市場の詳細データ

  • 製品別場シェア(2015年~2020年)
  • アプリケーション別市場シェア(2015年~2020年)

第10章 東南アジア市場の詳細データ

  • 製品別場シェア(2015年~2020年)
  • アプリケーション別市場シェア(2015年~2020年)

第11章 インド市場の詳細データ

  • 製品別場シェア(2015年~2020年)
  • アプリケーション別市場シェア(2015年~2020年)

第12章 企業プロファイルおよび主要データ

  • Hospira (Pfizer Inc.)
  • Baxter
  • Fresenius Kabi
  • Sandoz (Novartis)
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories Ltd
  • Grifols
  • Nichi-Iko Group (Sagent)
  • Teva Pharmaceutical
  • Otsuka
  • B.Braun
  • JW Life Science
  • Auromedics
  • Sanofi
  • Gland Pharma
  • Endo International PLC
  • Sichuan Kelun Pharmaceutical
  • Cisen Pharmaceutical
  • Shijiazhuang No. 4 Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • CR Double-Crane

第13章 製造コスト分析

  • 病院の注射剤主要原材料分析
    • 主要原材料
    • 原材料の主要サプライヤー
  • 製造コスト構造比
  • 製造プロセス分析
  • 産業チェーン分析

第14章 販売チャネル、販売代理店、および顧客

  • 販売チャネル
  • 販売代理店リスト
  • 顧客

第15章 市場力学

  • 市場動向
  • 市場機会と成長要因
  • 市場の課題
  • 市場の抑制要因
  • ポーターのファイブフォース分析

第16章 調査結果・結論

第17章 付録

図表

List of Tables and Figures

  • Table 1. Global Hospital Injectable Drugs Sales Growth Rate by Products (2020 & 2026) & (US$ Million)
  • Table 2. Global Hospital Injectable Drugs Sales Comparison by Application (2020-2026) & (US$ Million)
  • Table 3. Global Market Hospital Injectable Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
  • Table 4. Global Hospital Injectable Drugs Revenue (US$ Million) Market Share by Region (2015-2020)
  • Table 5. Global Hospital Injectable Drugs Revenue Share by Region (2015-2020)
  • Table 6. Global Hospital Injectable Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
  • Table 7. Global Hospital Injectable Drugs Revenue Share Forecast by Region (2021-2026)
  • Table 8. Global Hospital Injectable Drugs Revenue (US$ Million) by Company (2015-2020)
  • Table 9. Global Hospital Injectable Drugs Revenue Share by Company (2015-2020)
  • Table 10. Global Generic Sterile Injectables Sales (US$ Million) & (2015-2020)
  • Table 11. Global Generic Sterile Injectables Sales Market Share (2015-2020)
  • Table 12. Global Sterile Intravenous (IV) Solutions Sales by Company (US$ Million) & (2015-2020)
  • Table 13. Global Sterile Intravenous (IV) Solutions Sales Market Share by Company (2015-2020)
  • Table 14. Manufacturers Hospital Injectable Drugs Manufacturing Sites and Area Served
  • Table 15. Manufacturers Hospital Injectable Drugs Treatment Field
  • Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 17. Global Hospital Injectable Drugs Revenue (US$ Million) Market Share by Products (2015-2020)
  • Table 18. Global Hospital Injectable Drugs Revenue (US$ Million) Market Share by Products (2021-2026)
  • Table 19. Global Hospital Injectable Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
  • Table 20. Global Hospital Injectable Drugs Revenue Share by Application (2015-2020)
  • Table 21. Global Hospital Injectable Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
  • Table 22. North America Hospital Injectable Drugs Sales by Products (2015-2020) & (US$ Million)
  • Table 23. North America Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • Table 24. North America Hospital Injectable Drugs Sales by Application (2015-2020) & (US$ Million)
  • Table 25. North America Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
  • Table 26. Europe Hospital Injectable Drugs Sales by Products (2015-2020) & (US$ Million)
  • Table 27. Europe Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • Table 28. Europe Hospital Injectable Drugs Sales by Application (2015-2020) & (US$ Million)
  • Table 29. Europe Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
  • Table 30. China Hospital Injectable Drugs Sales (US$ Million) by Products (2015-2020)
  • Table 31. China Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • Table 32. China Hospital Injectable Drugs Sales (US$ Million) by Application (2015-2020)
  • Table 33. China Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
  • Table 34. Japan Hospital Injectable Drugs Sales (US$ Million) by Products (2015-2020)
  • Table 35. Japan Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • Table 36. Japan Hospital Injectable Drugs Sales (US$ Million) by Application (2015-2020)
  • Table 37. Japan Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
  • Table 38. Southeast Asia Hospital Injectable Drugs Sales (US$ Million) by Products (2015-2020)
  • Table 39. Southeast Asia Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • Table 40. Southeast Asia Hospital Injectable Drugs Sales (US$ Million) by Application (2015-2020)
  • Table 41. Southeast Asia Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
  • Table 42. India Hospital Injectable Drugs Sales (US$ Million) by Products (2015-2020)
  • Table 43. India Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • Table 44. India Hospital Injectable Drugs Sales (US$ Million) by Application (2015-2020)
  • Table 45. India Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
  • Table 46. Hospira (Pfizer Inc.) Corporation Information
  • Table 47. Hospira (Pfizer Inc.) Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 48. Hospira (Pfizer Inc.) Recent Developments
  • Table 49. Baxter Corporation Information
  • Table 50. Baxter Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 51. Baxter Recent Developments
  • Table 52. Fresenius Kabi Corporation Information
  • Table 53. Fresenius Kabi Description and Business Overview
  • Table 54. Fresenius Kabi Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 55. Fresenius Kabi Recent Developments
  • Table 56. Sandoz (Novartis) Corporation Information
  • Table 57. Sandoz (Novartis) Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 58. Sandoz (Novartis) Recent Developments
  • Table 59. Hikma Pharmaceuticals PLC Corporation Information
  • Table 60. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 61. Hikma Pharmaceuticals PLC Recent Developments
  • Table 62. Dr. Reddy's Laboratories Ltd Corporation Information
  • Table 63. Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 64. Dr. Reddy's Laboratories Ltd Recent Developments
  • Table 65. Grifols Corporation Information
  • Table 66. Grifols Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 67. Nichi-Iko Group (Sagent) Corporation Information
  • Table 68. Nichi-Iko Group (Sagent) Description and Business Overview
  • Table 69. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 70. Nichi-Iko Group (Sagent) Recent Developments
  • Table 71. Teva Pharmaceutical Corporation Information
  • Table 72. Teva Pharmaceutical Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 73. Teva Pharmaceutical Recent Developments
  • Table 74. Otsuka Corporation Information
  • Table 75. Otsuka Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 76. B.Braun Corporation Information
  • Table 77. B.Braun Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 78. JW Life Science Corporation Information
  • Table 79. JW Life Science Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 80. JW Life Science Recent Developments
  • Table 81. Auromedics Corporation Information
  • Table 82. Auromedics Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 83. Sanofi Corporation Information
  • Table 84. Sanofi Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 85. Sanofi Recent Developments
  • Table 86. Gland Pharma Corporation Information
  • Table 87. Gland Pharma Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 88. Endo International PLC Corporation Information
  • Table 89. Endo International PLC Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 90. Endo International PLC Recent Developments
  • Table 91. Sichuan Kelun Pharmaceutical Corporation Information
  • Table 92. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 93. Cisen Pharmaceutical Corporation Information
  • Table 94. Cisen Pharmaceutical Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 95. Shijiazhuang No. 4 Pharmaceutical Corporation Information
  • Table 96. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 97. Shandong Hualu Pharmaceutical Corporation Information
  • Table 98. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 99. CR Double-Crane Corporation Information
  • Table 100. CR Double-Crane Hospital Injectable Drugs Sales (US$ Million) and Gross Margin (2015-2020)
  • Table 101. Production Base and Market Concentration Rate of Raw Material
  • Table 102. Key Suppliers of Raw Materials
  • Table 103. Hospital Injectable Drugs Distributors List
  • Table 104. Hospital Injectable Drugs Customers List
  • Table 105. Hospital Injectable Drugs Market Key Trends
  • Table 106. Hospital Injectable Drugs Key Opportunities and Drivers
  • Table 107. Hospital Injectable Drugs Market Challenges
  • Table 108. Hospital Injectable Drugs Market Restraints
  • Table 109. Research Programs/Design for This Report
  • Table 110. Key Data Information from Secondary Sources
  • Table 111. Key Data Information from Primary Sources
  • Figure 1. Hospital Injectable Drugs Product Picture
  • Figure 2. Global Hospital Injectable Drugs Market Share by Products in 2020 & 2026
  • Figure 3. Vials Product Picture
  • Figure 4. Ampoules Product Picture
  • Figure 5. Global Hospital Injectable Drugs Market Share by Application in 2020 & 2026
  • Figure 6. Oncology Examples
  • Figure 7. Anesthesia Examples
  • Figure 8. Anti-Infectives Examples
  • Figure 9. Parenteral Nutrition Examples
  • Figure 10. Cardiovascular Diseases Examples
  • Figure 11. Global Hospital Injectable Drugs Revenue, (US$ Million), 2015 VS 2020 VS 2026
  • Figure 12. Global Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2015-2026)
  • Figure 13. Global Hospital Injectable Drugs Revenue Market Share by Region: 2015 - 2020
  • Figure 14. Global Hospital Injectable Drugs Revenue Market Share by Region: 2015 VS 2020
  • Figure 15. Global Hospital Injectable Drugs Revenue Market Share by Region: 2021 -2026
  • Figure 16. North America Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2015-2026)
  • Figure 17. Europe Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2015-2026)
  • Figure 18. China Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2015-2026)
  • Figure 19. Japan Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2015-2026)
  • Figure 20. Southeast Asia Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2015-2026)
  • Figure 21. India Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2015-2026)
  • Figure 22. Global Generic Sterile Injectables Sales Market Share in 2019
  • Figure 23. Global Top 3 Players of Generic Sterile Injectables Sales Market Share in 2019
  • Figure 24. Global Sterile Intravenous (IV) Solutions Sales Market Share by Company in 2019
  • Figure 25. Global Top 3 Players of Sterile Intravenous (IV) Solutions Sales Market Share in 2019
  • Figure 26. Global 3 Largest Hospital Injectable Drugs Players Market Share by Revenue in Hospital Injectable Drugs: 2015 & 2019
  • Figure 27. Global Hospital Injectable Drugs Revenue Share by Products (2015-2020)
  • Figure 28. Global Hospital Injectable Drugs Revenue Share by Products (2021-2026)
  • Figure 29. Global Hospital Injectable Drugs Revenue Growth Rate by Application in 2015 & 2019
  • Figure 30. Global Hospital Injectable Drugs Revenue Share by Application (2021-2026)
  • Figure 31. North America Hospital Injectable Drugs Sales Market Share by Products in 2019
  • Figure 32. Europe Hospital Injectable Drugs Sales Market Share by Products in 2019
  • Figure 33. Europe Hospital Injectable Drugs Sales Market Share by Application in 2019
  • Figure 34. China Hospital Injectable Drugs Sales Market Share by Products in 2019
  • Figure 35. China Hospital Injectable Drugs Sales Market Share by Application in 2019
  • Figure 36. Japan Hospital Injectable Drugs Sales Market Share by Products in 2019
  • Figure 37. Japan Hospital Injectable Drugs Sales Market Share by Application in 2019
  • Figure 38. Southeast Asia Hospital Injectable Drugs Sales Market Share by Products in 2019
  • Figure 39. Southeast Asia Hospital Injectable Drugs Sales Market Share by Application in 2019
  • Figure 40. India Hospital Injectable Drugs Sales Market Share by Products in 2019
  • Figure 41. India Hospital Injectable Drugs Sales Market Share by Application in 2019
  • Figure 42. Hospira (Pfizer Inc.) Hospital Injectable Parenteral Nutrition Drugs Product
  • Figure 43. Baxter Hospital Injectable Anti-Infectives Drugs Product
  • Figure 44. Fresenius Kabi Hospital Injectable Drugs Product
  • Figure 45. Sandoz (Novartis) Hospital Injectable Drugs Product
  • Figure 46. Hikma Pharmaceuticals PLC Hospital Injectable Product
  • Figure 47. Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Product
  • Figure 48. Grifols Hospital Injectable Drugs Product
  • Figure 49. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product
  • Figure 50. Teva Pharmaceutical Hospital Injectable Drugs Product
  • Figure 51. Otsuka Hospital Injectable Drugs Product
  • Figure 52. B.Braun Hospital Injectable Drugs Product
  • Figure 53. JW Life Science Hospital Injectable Drugs Product
  • Figure 54. Auromedics Hospital Injectable Drugs Product
  • Figure 55. Sanofi Hospital Injectable Drugs Product
  • Figure 56. Gland Pharma Hospital Injectable Drugs Product
  • Figure 57. Endo International PLC Hospital Injectable Drugs Product
  • Figure 58. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product
  • Figure 59. Cisen Pharmaceutical Hospital Injectable Drugs Product
  • Figure 60. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product
  • Figure 61. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product
  • Figure 62. CR Double-Crane Hospital Injectable Drugs Product
  • Figure 63. Manufacturing Cost Structure of Hospital Injectable Drugs
  • Figure 64. Manufacturing Process Analysis of Hospital Injectable Drugs
  • Figure 65. Hospital Injectable Drugs Industrial Chain Analysis
  • Figure 66. Channels of Distribution
  • Figure 67. Distributors Profiles
  • Figure 68. Porter's Five Forces Analysis
  • Figure 69. Bottom-up and Top-down Approaches for This Report
  • Figure 70. Data Triangulation
  • Figure 71. Key Executives Interviewed 102
目次

Market Analysis and Insights: Global Hospital Injectable Drugs Market

This hospital injectable drugs report focuses on the generic sterile injectables and sterile intravenous (IV) solutions.

The global hospital injectable drugs market is valued at USD 38.0 billion in 2019, and it is predicted to reach USD 51.0 billion in 2026, with a CAGR of 4.7 between 2021 and 2026.

In 2019, the global generic sterile injectables market size is USD 28.8 billion, and will reach USD 36.4 billion in 2026, with a CAGR of 3.5% during 2021 to 2026.

And the Sterile Intravenous (IV) Solutions global market size is 9.1 billion in 2019, and will be USD 14.6 billion, with a CAGR of 8.1% between 2021 and 2026.

In the segment of generic sterile injectables, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.

In the segment of sterile intravenous (IV) solutions, Baxter is the largest player, Fresenius Kabi and Sichuan Kelun Pharmaceutical are the second and the third. Top 3 players have a share over 65 percent in 2019. The North America and Europe market is dominated by few players like Baxter, Fresenius Kabi and B. Braun. And in Japan, Otsuka holds a share nearly 50% of Japanese market. China market the industry concentration is low, with lots of small players in China.

In the segment of generic sterile injectables, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.

In the segment of sterile intravenous (IV) solutions, Baxter is the largest player, Fresenius Kabi and Sichuan Kelun Pharmaceutical are the second and the third. Top 3 players have a share over 65 percent in 2019. The North America and Europe market is dominated by few players like Baxter, Fresenius Kabi and B. Braun. And in Japan, Otsuka holds a share nearly 50% of Japanese market. China market the industry concentration is low, with lots of small players in China.

Global Hospital Injectable Drugs Scope and Market Size

The global Hospital Injectable Drugs market is segmented by company, region (country), by Products, and by Application. Players, stakeholders, and other participants in the global Hospital Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Products and by Application for the period 2015-2026.

By Company

  • Hospira (Pfizer Inc.)
  • Baxter
  • Fresenius Kabi
  • Sandoz (Novartis)
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories Ltd
  • Grifols
  • Nichi-Iko Group (Sagent)
  • Teva Pharmaceutical
  • Otsuka
  • B.Braun
  • JW Life Science
  • Auromedics
  • Sanofi
  • Gland Pharma
  • Endo International PLC
  • Sichuan Kelun Pharmaceutical
  • Cisen Pharmaceutical
  • Shijiazhuang No. 4 Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • CR Double-Crane

Segment by Products

  • Generic Injectables
  • Sterile Intravenous (IV) Solutions

Segment by Application

  • Oncology
  • Anesthesia
  • Anti-Infectives
  • Parenteral Nutrition
  • Cardiovascular Diseases
  • Application Six

By Region

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Rest of World

TABLE OF CONTENTS

1 HOSPITAL INJECTABLE DRUGS MARKET OVERVIEW

  • 1.1 Hospital Injectable Drugs Product Scope
  • 1.2 Hospital Injectable Drugs Segment by Products
    • 1.2.1 Global Hospital Injectable Drugs Sales by Products (2020 & 2026)
    • 1.2.2 Generic Sterile Injectables
    • 1.2.3 Sterile Intravenous (IV) Solutions
  • 1.3 Hospital Injectable Drugs Segment by Application
    • 1.3.1 Global Hospital Injectable Drugs Sales Comparison by Application (2020-2026)
    • 1.3.2 Oncology
    • 1.3.3 Anesthesia
    • 1.3.4 Anti-Infectives
    • 1.3.5 Parenteral Nutrition
    • 1.3.6 Cardiovascular Diseases
  • 1.4 Global Hospital Injectable Drugs Market Estimates and Forecasts (2015-2026)

2 HOSPITAL INJECTABLE DRUGS ESTIMATES AND FORECASTS BY REGION

  • 2.1 Global Hospital Injectable Drugs Market Size by Region: 2015 VS 2020 VS 2026
  • 2.2 Global Hospital Injectable Drugs Retrospective Market Scenario by Region (2015-2020)
  • 2.3 Global Hospital Injectable Drugs Market Estimates and Forecasts by Region (2021-2026)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Hospital Injectable Drugs Estimates and Projections (2015-2026)
    • 2.4.2 Europe Hospital Injectable Drugs Estimates and Projections (2015-2026)
    • 2.4.3 China Hospital Injectable Drugs Estimates and Projections (2015-2026)
    • 2.4.4 Japan Hospital Injectable Drugs Estimates and Projections (2015-2026)
    • 2.4.5 Southeast Asia Hospital Injectable Drugs Estimates and Projections (2015-2026)
    • 2.4.6 India Hospital Injectable Drugs Estimates and Projections (2015-2026)

3 GLOBAL HOSPITAL INJECTABLE DRUGS COMPETITION LANDSCAPE BY PLAYERS

  • 3.1 Global Top Hospital Injectable Drugs Players by Sales (2015-2020)
  • 3.2 Generic Sterile Injectables Sales by Company
  • 3.3 Global Sterile Intravenous (IV) Solutions Sales by Company
  • 3.4 Manufacturers Hospital Injectable Drugs Manufacturing Sites, Area Served, Product Type
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 GLOBAL HOSPITAL INJECTABLE DRUGS MARKET SIZE BY PRODUCTS

  • 4.1 Global Hospital Injectable Drugs Historic Market Review by Products (2015-2020)
  • 4.2 Global Hospital Injectable Drugs Market Estimates and Forecasts by Products (2021-2026)

5 GLOBAL HOSPITAL INJECTABLE DRUGS MARKET SIZE BY APPLICATION

  • 5.1 Global Hospital Injectable Drugs Historic Market Review by Application (2015-2020)
  • 5.2 Global Hospital Injectable Drugs Market Estimates and Forecasts by Application (2021-2026)

6 NORTH AMERICA HOSPITAL INJECTABLE DRUGS MARKET FACTS & FIGURES

  • 6.1 North America Hospital Injectable Drugs Sales Market Share Breakdown by Products (2015-2020)
  • 6.2 North America Hospital Injectable Drugs Sales Market Share Breakdown by Application (2015-2020)

7 EUROPE HOSPITAL INJECTABLE DRUGS MARKET FACTS & FIGURES

  • 7.1 Europe Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • 7.2 Europe Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

8 CHINA HOSPITAL INJECTABLE DRUGS MARKET FACTS & FIGURES

  • 8.1 China Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • 8.2 China Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

9 JAPAN HOSPITAL INJECTABLE DRUGS MARKET FACTS & FIGURES

  • 9.1 Japan Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • 9.2 Japan Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

10 SOUTHEAST ASIA HOSPITAL INJECTABLE DRUGS MARKET FACTS & FIGURES

  • 10.1 Southeast Asia Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • 10.2 Southeast Asia Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

11 INDIA HOSPITAL INJECTABLE DRUGS MARKET FACTS & FIGURES

  • 11.1 India Hospital Injectable Drugs Sales Market Share by Products (2015-2020)
  • 11.2 India Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

12 COMPANY PROFILES AND KEY FIGURES IN HOSPITAL INJECTABLE DRUGS BUSINESS

  • 12.1 Hospira (Pfizer Inc.)
    • 12.1.1 Hospira (Pfizer Inc.) Corporation Information
    • 12.1.2 Hospira (Pfizer Inc.) Business Overview
    • 12.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.1.4 Hospira (Pfizer Inc.) Hospital Injectable Drugs Products Offered
    • 12.1.5 Hospira (Pfizer Inc.) Recent Developments
  • 12.2 Baxter
    • 12.2.1 Baxter Corporation Information
    • 12.2.2 Baxter Business Overview
    • 12.2.3 Baxter Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.2.4 Baxter Hospital Injectable Drugs Products Offered
    • 12.2.5 Baxter Recent Developments
  • 12.3 Fresenius Kabi
    • 12.3.1 Fresenius Kabi Corporation Information
    • 12.3.2 Fresenius Kabi Business Overview
    • 12.3.3 Fresenius Kabi Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.3.4 Fresenius Kabi Hospital Injectable Drugs Products Offered
    • 12.3.5 Fresenius Kabi Recent Developments
  • 12.4 Sandoz (Novartis)
    • 12.4.1 Sandoz (Novartis) Corporation Information
    • 12.4.2 Sandoz (Novartis) Business Overview
    • 12.4.3 Sandoz (Novartis) Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.4.4 Sandoz (Novartis) Hospital Injectable Drugs Products Offered
    • 12.4.5 Sandoz (Novartis) Recent Developments
  • 12.5 Hikma Pharmaceuticals PLC
    • 12.5.1 Hikma Pharmaceuticals PLC Corporation Information
    • 12.5.2 Hikma Pharmaceuticals PLC Business Overview
    • 12.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.5.4 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Products Offered
    • 12.5.5 Hikma Pharmaceuticals PLC Recent Developments
  • 12.6 Dr. Reddy's Laboratories Ltd
    • 12.6.1 Dr. Reddy's Laboratories Ltd Corporation Information
    • 12.6.2 Dr. Reddy's Laboratories Ltd Business Overview
    • 12.6.3 Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.6.4 Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Products Offered
    • 12.6.5 Dr. Reddy's Laboratories Ltd Recent Developments
  • 12.7 Grifols
    • 12.7.1 Grifols Corporation Information
    • 12.7.2 Grifols Business Overview
    • 12.7.3 Grifols Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.7.4 Grifols Hospital Injectable Drugs Products Offered
  • 12.8 Nichi-Iko Group (Sagent)
    • 12.8.1 Nichi-Iko Group (Sagent) Corporation Information
    • 12.8.2 Nichi-Iko Group (Sagent) Business Overview
    • 12.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.8.4 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Products Offered
    • 12.8.5 Nichi-Iko Group (Sagent) Recent Developments
  • 12.9 Teva Pharmaceutical
    • 12.9.1 Teva Pharmaceutical Corporation Information
    • 12.9.2 Teva Pharmaceutical Business Overview
    • 12.9.3 Teva Pharmaceutical Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.9.4 Teva Pharmaceutical Hospital Injectable Drugs Products Offered
    • 12.9.5 Teva Pharmaceutical Recent Developments
  • 12.10 Otsuka
    • 12.10.1 Otsuka Corporation Information
    • 12.10.2 Otsuka Business Overview
    • 12.10.3 Otsuka Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.10.4 Otsuka Hospital Injectable Drugs Products Offered
  • 12.11 B.Braun
    • 12.11.1 B.Braun Corporation Information
    • 12.11.2 B.Braun Business Overview
    • 12.11.3 B.Braun Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.11.4 B.Braun Hospital Injectable Drugs Products Offered
  • 12.12 JW Life Science
    • 12.12.1 JW Life Science Corporation Information
    • 12.12.2 JW Life Science Business Overview
    • 12.12.3 JW Life Science Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.12.4 JW Life Science Hospital Injectable Drugs Products Offered
    • 12.12.5 JW Life Science Recent Developments
  • 12.13 Auromedics
    • 12.13.1 Auromedics Corporation Information
    • 12.13.2 Auromedics Business Overview
    • 12.13.3 Auromedics Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.13.4 Auromedics Hospital Injectable Drugs Products Offered
  • 12.14 Sanofi
    • 12.14.1 Sanofi Corporation Information
    • 12.14.2 Sanofi Business Overview
    • 12.14.3 Sanofi Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.14.4 Sanofi Hospital Injectable Drugs Products Offered
    • 12.14.5 Sanofi Recent Developments
  • 12.15 Gland Pharma
    • 12.15.1 Gland Pharma Corporation Information
    • 12.15.2 Gland Pharma Business Overview
    • 12.15.3 Gland Pharma Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.15.4 Gland Pharma Hospital Injectable Drugs Products Offered
  • 12.16 Endo International PLC
    • 12.16.1 Endo International PLC Corporation Information
    • 12.16.2 Endo International PLC Business Overview
    • 12.16.3 Endo International PLC Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.16.4 Endo International PLC Hospital Injectable Drugs Products Offered
    • 12.16.5 Endo International PLC Recent Developments
  • 12.17 Sichuan Kelun Pharmaceutical
    • 12.17.1 Sichuan Kelun Pharmaceutical Corporation Information
    • 12.17.2 Sichuan Kelun Pharmaceutical Business Overview
    • 12.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.17.4 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Products Offered
  • 12.18 Cisen Pharmaceutical
    • 12.18.1 Cisen Pharmaceutical Corporation Information
    • 12.18.2 Cisen Pharmaceutical Business Overview
    • 12.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.18.4 Cisen Pharmaceutical Hospital Injectable Drugs Products Offered
  • 12.19 Shijiazhuang No. 4 Pharmaceutical
    • 12.19.1 Shijiazhuang No. 4 Pharmaceutical Corporation Information
    • 12.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
    • 12.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.19.4 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Products Offered
  • 12.20 Shandong Hualu Pharmaceutical
    • 12.20.1 Shandong Hualu Pharmaceutical Corporation Information
    • 12.20.2 Shandong Hualu Pharmaceutical Business Overview
    • 12.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.20.4 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Products Offered
  • 12.21 CR Double-Crane
    • 12.21.1 CR Double-Crane Corporation Information
    • 12.21.2 CR Double-Crane Business Overview
    • 12.21.3 CR Double-Crane Hospital Injectable Drugs Sales and Gross Margin (2015-2020)
    • 12.21.4 CR Double-Crane Hospital Injectable Drugs Products Offered

13 HOSPITAL INJECTABLE DRUGS MANUFACTURING COST ANALYSIS

  • 13.1 Hospital Injectable Drugs Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Hospital Injectable Drugs
  • 13.4 Hospital Injectable Drugs Industrial Chain Analysis

14 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 14.1 Marketing Channel
  • 14.2 Hospital Injectable Drugs Distributors List
  • 14.3 Hospital Injectable Drugs Customers

15 MARKET DYNAMICS

  • 15.1 Hospital Injectable Drugs Market Trends
  • 15.2 Hospital Injectable Drugs Opportunities and Drivers
  • 15.3 Hospital Injectable Drugs Market Challenges
  • 15.4 Hospital Injectable Drugs Market Restraints
  • 15.5 Porter's Five Forces Analysis

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

  • 17.1 Research Methodology
    • 17.1.1 Methodology/Research Approach
    • 17.1.2 Data Source
  • 17.2 Author Details
  • 17.3 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.